Archives: Synthetic and other drugs

Subscribe to Synthetic and other drugs RSS Feed

U.S. Department of Transportation Expands Its Drug Testing Panel Effective January 1, 2018

The U.S. Department of Transportation announced in a rule published in the Federal Register on November 13, 2017, that, among other revisions to its drug and alcohol testing regulations, it will expand its drug testing panel to include four “semi-synthetic” opioid drugs: hydrocodone, hydromorphone, oxycodone and oxymorphone.  These changes are being made to harmonize DOT’s … Continue Reading

DEA Classifies U-47700, or “Pink”, As A Schedule I Drug

The Drug Enforcement Administration (“DEA”) announced September 7, 2016 that it intends to temporarily schedule the synthetic opioid known as U-47700 on Schedule I of the federal Controlled Substances Act because it poses an imminent hazard to the public safety. A final scheduling order will be made on or after October 7, 2016.  Schedule I … Continue Reading

FDA Warns Against Mixing Opioid Medications and Benzodiazepines

As part of the federal government’s efforts to address the opioid abuse epidemic, the U.S. Food and Drug Administration (“FDA”) issued a safety announcement on August 31, 2016, advising against the mixture of opioid medications and benzodiazepines. Specifically, a FDA review found that combining opioid medicines with benzodiazepines or other drugs that depress the central … Continue Reading

DEA Intends to Classify Kratom as a Schedule I Drug

The Drug Enforcement Administration (“DEA”) announced August 30, 2016 that it intends to add the opioids Mitragynine and 7-Hydroxymitragynine, also known as Kratom, to the list of Schedule I drugs under the federal Controlled Substances Act because Kratom poses an imminent hazard to public safety. Kratom is a tropical tree indigenous to Thailand, Malaysia, Myanmar, … Continue Reading

National Safety Council Urges Employers to Take Steps to Address Employee Addiction to Opioid Pain Medications

The National Safety Council (“NSC”) has published a report entitled Prescription Pain Medications: A Fatal Cure For Injured Workers, urging employers to educate employees about the dangers of using opioid pain medications – such as addiction and death – while also taking steps to avoid potential liability in workers’ compensation and personal injury litigation. The … Continue Reading

DHHS Proposes Rules Permitting Oral Fluid Drug Testing and Synthetic Opiate Testing

The U.S. Department of Health and Human Services (“DHHS”) proposed new guidelines in the Federal Register on May 15, 2015 that would revise the Mandatory Guidelines for Federal Workplace Drug Testing Programs in two significant ways: (1) to permit the testing of oral fluid specimens for drugs; and (2) to include drug testing for certain … Continue Reading

New York Governor Issues Health Alert After Surge In Hospitalizations Due to Synthetic Marijuana Use

Governor Andrew M. Cuomo issued a health alert on April 16, 2015 warning New Yorkers that a recent increase in the use of synthetic marijuana has caused more than 160 people to be hospitalized since April 8th. Synthetic marijuana consists of plant material coated by chemicals which mimic THC, the active component of marijuana. Popularly … Continue Reading
LexBlog